Noksira Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 20-12-2024
- Paid Up Capital ₹ 0.10 M
as on 20-12-2024
- Company Age 12 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
as on 20-12-2024
- Revenue -8.55%
(FY 2017)
- Profit -53.23%
(FY 2017)
- Ebitda -86.77%
(FY 2017)
- Net Worth 76.12%
(FY 2017)
- Total Assets 48.13%
(FY 2017)
About Noksira Pharma
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Barun Singh and Dinesh Singh serve as directors at the Company.
- CIN/LLPIN
U24297DL2012PTC240740
- Company No.
240740
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Noksira Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Barun Singh  | Director | 23-Aug-2012 | Current |
| Dinesh Singh | Director | 23-Aug-2012 | Current |
Financial Performance of Noksira Pharma.
Noksira Pharma Private Limited, for the financial year ended 2017, experienced Minor drop in revenue, with a 8.55% decrease. The company also saw a substantial fall in profitability, with a 53.23% decrease in profit. The company's net worth Soared by an impressive increase of 76.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Noksira Pharma?
In 2017, Noksira Pharma had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ariskon Pharma Private LimitedActive 17 years 8 monthsBarun Singh and Dinesh Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 May 2020 | ₹1.00 M | Open |
How Many Employees Work at Noksira Pharma?
Unlock and access historical data on people associated with Noksira Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Noksira Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Noksira Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
